Serum LOX-1 is a novel prognostic biomarker of colorectal cancer.

Chiyo Nakashima-NakasugaShoichi HazamaNobuaki SuzukiYuki NakagamiMing XuShin YoshidaShinobu TomochikaNobuyuki FujiwaraSatoshi MatsukumaHiroto MatsuiYukio TokumitsuShinsuke KanekiyoYoshitaro ShindoNoriko MaedaRyouichi TsunedomiMichihisa IidaShigeru TakedaShigefumi YoshinoTomio UenoYoshihiko HamamotoHiroyuki OgiharaYoshinobu HoshiiHiroaki Nagano

Published in: International journal of clinical oncology (2020)

Serum LOX-1 might be a useful biomarker of poor prognosis in colorectal cancer.

Keyphrases

poor prognosis
long non coding rna
low density lipoprotein